58
Participants
Start Date
November 30, 1997
Primary Completion Date
May 31, 2002
Study Completion Date
May 31, 2002
aldesleukin
rituximab
University of Rochester Cancer Center, Rochester
National Cancer Institute (NCI)
NIH
University of Rochester
OTHER